Are NCI’s efforts affiliated with the NIH Roadmap or the National Nanotechnology Initiative?
NCI’s Cancer Nanotechnology Initiative is separate from, but coordinated with, both the National Institutes of Health (NIH) Roadmap activity and the National Nanotechnology Initiative. The NIH Roadmap is focusing on challenges and opportunities associated with basic research, whereas the majority of NCI’s research initiatives are focusing on using knowledge from this basic research and translating it into clinical products. There are several areas where NIH’s Roadmap activity and NCI’s Cancer Nanotechnology Plan (CNPlan) have provided mutual support. The NIH Roadmap Nanomedicine Implementation Group is planning to fund development awards for Nanomedicine Center development by the end of 2005. The goal of this initiative is to fund Centers using and developing nanotechnology to examine biological processes compatible to the missions of the various NIH institutes. This supports a long term goal of the NIH to support infrastructure development in nanomedicine. In contrast, the CNPlan capi
